Tilray (TLRY) Medical, a division of Tilray Brands, announced that its wholly-owned subsidiary, FL Group, has entered into a strategic partnership with L. Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A., an Italian pharmaceutical firm specializing in pain therapies and substance dependence. The partnership is designed to broaden the availability of Tilray Medical cannabis extracts for patients across Italy. Molteni will collaborate with FL Group by providing targeted education on medical cannabis therapies through Molteni’s comprehensive network of pharmaceutical, scientific, and medical professionals throughout Italy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Why Is Tilray Stock Price (TLRY) Exploding?
- Unusually active option classes on open August 12th
- Tilray expands hemp-derived Delta-9 THC beverage lineup
- Trump Trade: Nvidia, AMD said to pay U.S. cut from China chip sales
- Unusually active option classes on open August 11th